Ultragenyx Pharma (RARE) – PRNewswire
-
Andelyn Biosciences Selected by Ultragenyx for Late-Stage Process Performance Qualification (PPQ) Manufacturing of Novel Gene Therapy for Sanfilippo Syndrome
-
GATT Technologies Announces €10.5M Series B Funding, Appointment of New CEO, and Expansion of Supervisory Board to Lead Company Through Next Development Stage
-
REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder
Back to RARE Stock Lookup
